Stents

This channel includes news and new technology innovations for stents, also called vascular scaffolds. Stents are used to help prop open a vessel treated by balloon angioplasty because of the barotrauma caused by the extreme stretching of vessel walls. The stent enables to vessel to heal in an open position with collapsing. Drug eluting stents (DES) are coated in anti-proliferative drugs to precent scar tissue growth which can cause restenosis and occlude the vessel. DES require antiplatelet therapy because the drug carrier polymer on DES can cause thrombus inside the stent, even years after treatment, which is why bare metal stents are still used in some patients. This page includes news on coronary stents, carotid stents, peripheral stents, bioresorbable stents, and renal stents. 

News | Stents Drug Eluting

October 26, 2015 — OrbusNeich announced the presentation of the one-year clinical outcomes from the 1,000-patient REMEDE ...

Home October 26, 2015
Home
News | Stents

October 26, 2015 — Medinol announced in September the completion of enrollment in its BIONICS trial to evaluate the ...

Home October 26, 2015
Home
News | Stents Drug Eluting

October 23, 2015 — Results of the TUXEDO trial, designed to compare two types of stents in diabetic patients, found ...

Home October 23, 2015
Home
ISAR-DESIRE 4 trial, TCT 2015, drug-coated balloon, DCB, scoring balloon, SCB, drug-eluting stent restenosis
Feature | Drug-Eluting Balloons

October 22, 2015 — Results from the ISAR-DESIRE 4 trial indicate that use of a scoring balloon plus a paclitaxel-coated ...

Home October 22, 2015
Home
Amaranth Fortitute Bioresorbable stent
Feature | TCT | Tom Watson, BS, RCVT, Clinical Analyst, MD Buyline

There were several overarching technology trends seen at the 2015 Transcatheter Cardiovascular Therapeutics (TCT) annual ...

Home October 19, 2015
Home
News | Stents Bioresorbable

October 16, 2015 — Enrollment has successfully concluded in its multi-center, international CE mark clinical trials MEND ...

Home October 16, 2015
Home
ABSORB III trial, TCT 2015, bioresorbable vascular scaffold, BVS
Feature | Stents Bioresorbable

October 16, 2015 — Results from a clinical trial showed that Abbott's Absorb everolimus-eluting bioresorbable vascular ...

Home October 16, 2015
Home
News | Stents Bioresorbable

October 15, 2015 — Two new advances in stent technology announced in recent days further reinforce the effectiveness of ...

Home October 15, 2015
Home
News | Stents Bioresorbable

October 15, 2015 — Biotronik has announced results from the BIOSOLVE-II trial, investigating the safety and clinical ...

Home October 15, 2015
Home
News | Stents Bifurcation

October 14, 2015 — Tryton Medical Inc. announced results from the pivotal Tryton Confirmatory Study confirming the ...

Home October 14, 2015
Home
Technology

October 5, 2015 — The U.S. Food and Drug Administration (FDA) has approved Boston Scientific’s Synergy Bioabsorbable ...

Home October 05, 2015
Home
News | Stents Bifurcation

October 2, 2015 — Tryton Medical Inc. announced that results of a post hoc analysis of the pivotal Tryton Randomized ...

Home October 02, 2015
Home
News | Stents Peripheral

October 1, 2015 — Kimihiko Kichikawa, M.D., department of radiology at Nara Medical University in Japan, reported two ...

Home October 01, 2015
Home
News | Stents Peripheral

October 1, 2015 — Stentys announced that the company’s drug-eluting stent received CE Mark for treatment of below-the ...

Home October 01, 2015
Home
Subscribe Now